[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100538137":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":23,"centralContacts":24,"locations":33,"responsibleParty":59,"collaborators":23,"id":62,"slug":23,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":23,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":23,"overallStatus":36,"whyStopped":23,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Tampere University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"NIV initiation in outpatient clinic in patients with ALS","ACTIVE_COMPARATOR","Starting the NIV at the outpatient clinic",[13],"Other: NIV initiation in patients with ALS",{"label":15,"type":10,"description":16,"interventionNames":17},"NIV initiation in pulmonary ward in patients with ALS","Starting the NIV in the pulmonary ward",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"NIV initiation in patients with ALS","NIV initiation according to standard care",[9,15],null,[25,30],{"name":26,"role":27,"phone":28,"phoneExt":23,"email":29},"Heidi A Rantala, MD, PhD","CONTACT","+3583311611","heidi.rantala@tuni.fi",{"name":31,"role":27,"phone":28,"phoneExt":23,"email":32},"Hanna Korkeamäki, MD, MSc","hanna.korkeamaki@pirha.fi",[34],{"facility":35,"status":36,"city":37,"state":23,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Tampere University Hospital","RECRUITING","Tampere","33520","Finland","FI",{"type":42,"coordinates":43},"Point",[44,45],23.78712,61.49911,{"lat":45,"lon":44},[48,49,52,54,57],{"name":26,"role":27,"phone":28,"phoneExt":23,"email":29},{"name":50,"role":27,"phone":28,"phoneExt":23,"email":51},"Lauri Lehtimäki, MD, PhD","lauri.lehtimaki@tuni.fi",{"name":31,"role":53,"phone":23,"phoneExt":23,"email":23},"PRINCIPAL_INVESTIGATOR",{"name":55,"role":56,"phone":23,"phoneExt":23,"email":23},"Hannele Hasala, MD, PhD","SUB_INVESTIGATOR",{"name":58,"role":56,"phone":23,"phoneExt":23,"email":23},"Sirpa Leivo-Korpela, MD, PhD",{"type":53,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":35,"oldNameTitle":23,"oldOrganization":23},"Heidi Rantala","Consultant","100538137",false,"NCT06286917","Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency","InNIVALS","Inclusion Criteria:\n\n* ALS diagnosed by a neurology and\n* chronic respiratory insufficiency or significant respiratory muscle weakness caused by ALS\n\nExclusion Criteria:\n\n* impaired cognition to give informed consent to participation\n* contraindication to NIV therapy\n* another severe disease with a prognosis of less than one year\n* ventilation via an artificial airway, tracheostomy","ALL","18 Years","99 Years",{"count":72,"type":73},120,"ESTIMATED","INTERVENTIONAL",[76],"NA","This research will study whether noninvasive ventilation (NIV) used to treat chronic respiratory insufficiency in patients with amyotrophic lateral sclerosis (ALS) can be initiated as successfully in the outpatient setting as in the conventional inpatient setting, and what the costs of these alternative initiation methods are.",[79,80,81],"Ventilation Therapy","ALS","Chronic Respiratory Failure","2026-01-23",{"date":84,"type":85},"2026-01-27","ACTUAL",{"date":87,"type":85},"2024-03-05",{"date":89,"type":73},"2029-12",{"name":5,"class":6},1]